Coming into play here
Helius Medical Technologies (CSE: HSM; OTCQB: HSDT) Inventors' Granted US Patent No. 14/341,141
"Non-Invasive Neuromodulation (NINM) For Rehabilitation of Brain Function"
NEWTOWN, PA / TheNewswire / April 14, 2015 - Helius Medical Technologies, Inc. (CSE: HSM; OTCQB: HSDT) ("Helius", or the "Company") announced today that the US Patent and Trademark Office (USPTO) issued a third patent related to its Portable Neuromodulation Stimulation (PoNS(TM)) device and the associated therapeutic modality. U.S. Patent No. 14/341,141 "Non-Invasive Neuromodulation (NINM) for Rehabilitation of Brain Function", issued on April 10, 2015, is directed to a non-invasive neuromodulation therapy that uses intraoral cutaneous stimulation in conjunction with cognitive exercise.
Cranial Nerve - Non Invasive Neuromodulation (CN-NINM) therapy is believed to facilitate the brain's ability to rehabilitate and compensate for symptoms caused by disease or trauma. The PoNS(TM) device and the CN-NINM therapy is currently being studied in the United States for the treatment of chronic balance disorders caused by mild-moderate Traumatic Brain Injury ("TBI") and in Canada for chronic balance and gait disorders caused by Multiple Sclerosis.
"Our growing patent portfolio continues to protect our vision to revolutionize the treatment of brain injury symptoms. Protecting our unique technology and therapeutic modality is fundamental for our growth as a company and our ability to properly and aggressively reshape this space," said Philippe Deschamps, Chief Executive Officer of Helius.
This USPTO issuance is the third patent Helius has received related to the PoNS(TM) device and the associated therapeutic modality. The first PoNS(TM) patent, US Patent No. 8,849,407, was issued on September 30, 2014. The second PoNS(TM) patent, US Patent No. 8,909,345 was issued on December 9, 2014. The Company also filed more than two dozen patent applications to protect the valuable technical features and ornamental design elements of the PoNS(TM) device. Helius expects to file additional patent applications to protect its technology, designs and therapeutic methods as they evolve.
About Helius Medical Technologies (HMT)
Helius Medical Technologies is a medical technology company focused on neurological wellness. The company's mission is to develop, license and acquire non-invasive treatments designed to help patients affected by neurological symptoms caused by disease or trauma. For more information, please visit www.heliusmedical.com.
